Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

SELL
$3.46 - $7.98 $2,771 - $6,391
-801 Reduced 6.87%
10,864 $67,000
Q4 2022

Feb 14, 2023

BUY
$5.26 - $12.19 $689 - $1,596
131 Added 1.14%
11,665 $71,000
Q3 2022

Nov 18, 2022

SELL
$9.86 - $15.76 $9,485 - $15,161
-962 Reduced 7.7%
11,534 $138,000
Q2 2022

Aug 15, 2022

SELL
$7.43 - $13.0 $58,355 - $102,102
-7,854 Reduced 38.59%
12,496 $158,000
Q1 2022

May 16, 2022

SELL
$7.73 - $17.99 $21,466 - $49,958
-2,777 Reduced 12.01%
20,350 $229,000
Q4 2021

Feb 15, 2022

BUY
$16.5 - $25.48 $4,785 - $7,389
290 Added 1.27%
23,127 $410,000
Q3 2021

Nov 15, 2021

BUY
$17.81 - $24.87 $73,555 - $102,713
4,130 Added 22.08%
22,837 $526,000
Q2 2021

Aug 16, 2021

SELL
$22.19 - $31.55 $37,234 - $52,940
-1,678 Reduced 8.23%
18,707 $435,000
Q1 2021

May 18, 2021

BUY
$26.99 - $40.0 $550,191 - $815,400
20,385 New
20,385 $635,000

Others Institutions Holding KNTE

About Kinnate Biopharma Inc.


  • Ticker KNTE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,145,600
  • Description
  • Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...
More about KNTE
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.